Skip to main content
SpringerLink
Log in

Apoptosis in Cardiovascular Remodeling—Effect of Medication

  • Published:
Cardiovascular Drugs and Therapy Aims and scope Submit manuscript

Abstract

In the last decade, apoptosis has emerged as a key determinant of target organ damage in cardiovascular diseases. The suggestion that increased cardiomyocyte apoptosis participates in the etiology of heart failure probably contributed to the negative view of the prevalence of apoptosis in the field of cardiovascular diseases. However, we and others have shown that up-regulation of apoptosis in certain cardiovascular cells may contribute to the beneficial action of antihypertensive drugs on target-organ structure. As an explanation for this apparent discrepancy, the same stimulus, e.g. angiotensin II, can induce apoptosis or stimulate cell growth in different cell types (e.g., cardiomyocytes and fibroblasts, respectively). Using the angiotensin pathway as a paradigm, this review proposes an integrative view of cell growth and cell death regulation in cardiovascular cells in order to illustrate how cell-specific responses to the same stimulus may in part explain the patterns of cell population dynamics during the development and treatment of target organ damage in hypertension.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Haunstetter A, Izumo S. Apoptosis: Basic mechanisms and implications for cardiovascular disease. Circ Res 1998; 82: 1111-1129.

    Google Scholar 

  2. Anversa P, Olivetti G, Leri A, et al. Myocyte cell death and ventricular remodeling. Curr Opin Nephrol Hypertens 1997; 6: 169-176.

    Google Scholar 

  3. deBlois D, Tea B-S, Dam T-V, et al. Smooth muscle cell apoptosis during vascular regression in spontaneously hypertensive rats. Hypertension 1997; 29: 340-349.

    Google Scholar 

  4. Sharifi AM, Schiffrin EL. Apoptosis in aorta of deoxycorticosterone acetate-salt hypertensive rats: Effect of endothelin receptor antagonism. J. Hypertens 1997; 15: 1441-1448.

    Google Scholar 

  5. Sharifi AM, Schiffrin EL. Apoptosis in vasculature of spontaneously hypertensive rats: Effect of an angiotensin converting enzyme inhibitor and a calcium channel antagonist. Am J Hypertens 1998; 11: 1108-1116.

    Google Scholar 

  6. Tea BS, Dam TV, Moreau P, et al. Apoptosis during regression of cardiac hypertrophy in spontaneously hypertensive rats: Temporal regulation and spatial heterogeneity. Hypertension 1999; 34: 229-235.

    Google Scholar 

  7. Tea BS, Der Sarkissian S, Touyz RM, et al. Proapoptotic and growth-inhibitory role of angiotensin II type 2 receptor in vascular smooth muscle cells of spontaneously hypertensive rats in vivo. Hypertension 2000; 35: 1069-1073.

    Google Scholar 

  8. Lemay J, Hamet P, deBlois D. Losartan-induced apoptosis as a novel mechanism for the prevention of vascular lesion formation after vascular injury. J Renin-Angiotensin-Aldosterone System 2000; 1: 39-42.

    Google Scholar 

  9. Sadoshima J, Izumo S. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of the AT1 receptor subtype. Circ Res 1993; 73: 413-423.

    Google Scholar 

  10. Leri A, Claudio PP, Li Q, et al. Stretch-mediated release of angiotensin II induces myocyte apoptosis by activating p53 that enhances the local renin-angiotensin system and decreases the Bcl-2-to-Bax protein ratio in the cell. J Clin Invest 1998; 101: 1326-1342.

    Google Scholar 

  11. Horiuchi M, Akishita M, Dzau VJ. Molecular and cellular mechanism of angiotensin II-mediated apoptosis. Endocrine Res 1998; 24: 307-314.

    Google Scholar 

  12. Folkow B. Physiological aspects of primary hypertension. Physol Rev 1982; 62: 347-504.

    Google Scholar 

  13. Hamet P. Proliferation and apoptosis in hypertension. Curr Opin Nephrol Hypertens 1995; 4: 1-7.

    Google Scholar 

  14. Lijnen P, Petrov V. Renin-angiotensin system, hypertrophy and gene expression in cardiac myocytes. J Mol Cell Cardiol 1999; 31: 949-970.

    Google Scholar 

  15. Beltrami AP, Urbanek K, Kajstura J, et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 2001; 344: 1750-1757.

    Google Scholar 

  16. Sadoshima J, Izumo S. Molecular characterization of angiotensin II-induced hypertrophy of cardiac myocytes and hyperplasia of cardiac fibroblasts. Critical role of angiotensin II. Circ Res 1994; 73: 413-423.

    Google Scholar 

  17. Bondjers G, Glukhova M, Hansson GK, et al. Hypertension and atherosclerosis: Cause and effect, or two effects with one unknown cause? Circulation 1991; 84(Suppl 6): 2-16.

    Google Scholar 

  18. Schwartz SM, deBlois D, O'Brien ER. The intima. Soil for atherosclerosis and restenosis. Circ Res 1995; 77: 445-465.

    Google Scholar 

  19. Gobe G, Browning J, Howard T, et al. Apoptosis occurs in endothelial cells during hypertension-induced microvascular rarefaction. J Struct Biol 1997; 118: 63-72.

    Google Scholar 

  20. Kockx MM, Knaapen MW. The role of apoptosis in vascular disease. J Pathol 2000; 190: 267-280.

    Google Scholar 

  21. Walter SV, Hamet P. Enhanced DNA synthesis in heart and kidney of newborn spontaneously hypertensive rats. Hypertension 1986; 8: 520-525.

    Google Scholar 

  22. Hamet P, Richard L, Dam T-V, et al. Apoptosis in target organs of hypertension. Hypertension 1995; 26: 642-648.

    Google Scholar 

  23. Lemay J, Tea BS, Hamet P, et al. Regression of neointimed lesions in the carotif artery of nifedipine-treated SHR and WKY rats: Possible role of apoptosis. J Vasc Res 2001; 38: 462-470.

    Google Scholar 

  24. Moreau P, Tea BS, Dam TV, et al. Altered balance between cell replication and apoptosis in hearts and kidneys of newborn SHR. Hypertension 1997; 30: 720-724.

    Google Scholar 

  25. Diez J, Panizo A, Hernandez M, et al. Cardiomyocyte apoptosis and cardiac angiotensin-converting enzyme in spontaneously hypertensive rats. Hypertension 1997; 30: 1029-1034.

    Google Scholar 

  26. Li Z, Bing OH, Long X, et al. Increased cardiomyocyte apoptosis during the transition to heart failure in the spontaneously hypertensive rat. Am J Physiol 1997; 272: H2313-H2319.

    Google Scholar 

  27. Fortuno MA, Ravassa S, Etayo JC, et al. Overexpression of Bax protein and enhanced apoptosis in the left ventricle of spontaneously hypertensive rats: Effects of AT1 blockade with losartan. Hypertension 1998; 32: 280-286.

    Google Scholar 

  28. Linz W, Jessen T, Becker RH, et al. Long-term ACE inhibition doubles lifespan of hypertensive rats. Circulation 1997; 96: 3164-3172.

    Google Scholar 

  29. Leri A, Fiordaliso F, Setoguchi M, et al. Inhibition of p53 function prevents renin-angiotensin system activation and stretch-mediated myocyte apoptosis. Am J Pathol 2000; 157: 843-857.

    Google Scholar 

  30. Ravassa S, Fortuno MA, Gonzalez A, et al. Mechanisms of increased susceptibility to angiotensin II-induced apoptosis in ventricular cardiomyocytes of spontaneously hypertensive rats. Hypertension 2000; 36: 1065-1071.

    Google Scholar 

  31. Leri A, Liu Y, Claudio PP, et al. Insulin-like growth factor-1 induces Mdm2 and down-regulates p53, attenuating the myocyte renin-angiotensin system and stretch-mediated apoptosis. Am J Pathol 1999; 154: 567-580.

    Google Scholar 

  32. Diez J, Panizo A, Hernandez M, et al. Is the regulation of apoptosis altered in smooth muscle cells of adult spontaneously hypertensive rats? Hypertension 1997; 29: 776-780.

    Google Scholar 

  33. Schiffrin EL, Deng LY, Larochelle P. Progressive improvement in the structure of resistance arteries of hypertensive patients after 2 years of treatment with an angiotensin I-converting enzyme inhibitor. Comparison with effects of a beta-blocker. Am J Hypertens 1995; 8: 229-236.

    Google Scholar 

  34. Opie LH, Sack MN. Enhanced angiotensin II activity in heart failure: Reevaluation of the counterregulatory hypothesis of receptor subtypes. Circ Res 2001; 88: 654-658.

    Google Scholar 

  35. deBlois D, Der Sarkissian S, Tea BS, et al. Caspase-3 activation and selective induction of apoptosis in noncardiomyocytes by valsartan in spontaneously hypertensive rats. J Renin-Angiotensin-Aldosterone System 2000; 1:60 (Abstract).

    Google Scholar 

  36. Pollman MJ, Yamada T, Horiuchi M, et al. Vasoactive substances regulate vascular smooth muscle cell apoptosis. Countervailing influences of nitric oxide and angiotensin II. Circ Res 1996; 79: 748-756.

    Google Scholar 

  37. Xie K, Huang S, Wang Y, et al. Bcl-2 protects cells from cytokine-induced nitric oxide-dependent apoptosis. Cancer Immunol Immunother 1996; 43: 109-115.

    Google Scholar 

  38. Khan S, Kayahara M, Joashi U, et al. Differential induction of apoptosis in Swiss 3T3 cells by nitric oxide and the nitrosonium cation. J Cell Sci 1997; 110: 2315-2322.

    Google Scholar 

  39. Horiuchi M, Akishita M, Dzau VJ. Recent progress in angiotensin II type 2 receptor research in the cardiovascular system. Hypertension 1999; 33: 613-621.

    Google Scholar 

  40. Diep QN, Li JS, Schiffrin EL. In vivo study of AT(1) and AT(2) angiotensin receptors in apoptosis in rat blood vessels. Hypertension 1999; 34: 617-624.

    Google Scholar 

  41. Der Sarkissian S, Tea BS, Hamet P, et al. An AT2 receptor antagonist prevents the antiproliferative and pro-apoptotic effects of valsartan in non-cardiomyocytes in theSHRheart. Canadian J Cardiol 1999; 15: 213D (abstract).

    Google Scholar 

  42. Hamet P, Hadrava V, Kruppa U, et al. Vascular smooth muscle cell hyperresponsiveness to growth factors in hypertension. J Hypertens Suppl 1988; 6: S36-S39.

    Google Scholar 

  43. Thorin-Trescases N, deBlois D, Hamet P. Evidence of altered in vivo vascular turnover in SHR and effect of a chronic antihypertensive treatment. Can J Physiol Pharmacol 2001; 79(6): 471-480.

    Google Scholar 

  44. Hamet P, Thorin-Trescases N, Moreau P, et al. Workshop: Excess growth and apoptosis: Is hypertension a case of accelerated aging of cardiovascular cells? Hypertension 2001; 37: 760-766.

    Google Scholar 

  45. Stoll M, Steckelings UM, Paul M, et al. The angiotensinAT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells. J. Clin. Invest. 1995; 95: 651-657.

    Google Scholar 

  46. Dimmeler S, Rippmann V, Weiland U, et al. Angiotensin II induces apoptosis of human endothelial cells. Protective effect of nitric oxide. Circ Res 1997; 81: 970-976.

    Google Scholar 

  47. Booz GW, Baker KM. Role of type 1 and type 2 angiotensin receptors in angiotensin II-induced cardiomyocyte hypertrophy. Hypertension 1996; 28: 635-640.

    Google Scholar 

  48. Ichihara S, Senbonmatsu T, Price E, Jr., et al. Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension. Circulation 2001; 104: 346-351.

    Google Scholar 

  49. Senbonmatsu T, Ichihara S, Price E, Jr., et al. Evidence for angiotensin II type 2 receptor-mediated cardiac myocyte enlargement during in vivo pressure overload. J Clin Invest 2000; 106: R25-R29.

    Google Scholar 

  50. Tsutsumi Y, Matsubara H, Ohkubo N, et al. Angiotensin II type 2 receptor is upregulated in human heart with interstitial fibrosis, and cardiac fibroblasts are the major cell type for its expression. Circ Res 1998; 83: 1035-1046.

    Google Scholar 

  51. Katoh M, Egashira K, Usui M, et al. Cardiac angiotensin II receptors are upregulated by long-term inhibition of nitric oxide synthesis in rats. Circ Res 1998; 83: 743-751.

    Google Scholar 

  52. Ohkubo N, Matsubara H, Nozawa Y, et al. Angiotensin type 2 receptors are reexpressed by cardiac fibroblasts from failing myopathic hamster hearts and inhibit cell growth and fibrillar collagen metabolism. Circulation 1997; 96: 3954-3962.

    Google Scholar 

  53. Makino N, Sugano M, Otsuka S, et al. Molecular mechanism of angiotensin II type I and type II receptors in cardiac hypertrophy of spontaneously hypertensive rats. Hypertension 1997 30 796-802.

    Google Scholar 

  54. Haywood GA, Gullestad L, Katsuya T, et al. AT1 and AT2 angiotensin receptor gene expression inhumanheart failure. Circulation 1997; 95: 1201-1206.

    Google Scholar 

  55. Dzau VJ, Horiuchi M. Differential expression of angiotensin receptor subtypes in the myocardium: A hypothesis [editorial; comment]. Eur Heart J 1996; 17: 978-980.

    Google Scholar 

  56. Ford WR, Clanachan AS, Jugdutt BI. Opposite effects of angiotensin AT1 and AT2 receptor antagonists on recovery of mechanical function after ischemia-reperfusion in isolated working rat hearts. Circulation 1996; 94: 3087-3089.

    Google Scholar 

  57. Horiuchi M, Hayashida W, Akishita M, et al. Stimulation of different subtypes of angiotensin II receptors, AT1 and AT2 receptors, regulates STAT activation by negative crosstalk. Circ Res 1999; 84: 876-882.

    Google Scholar 

  58. Levy BI, Benessiano J, Henrion D, et al. Chronic blockade of AT2-subtype receptors prevents the effect of angiotensin II on the rat vascular structure. J Clin Invest 1996; 98: 418-425.

    Google Scholar 

  59. Sabri A, Levy BI, Poitevin P, et al. Differential roles of AT1 and AT2 receptor subtypes in vascular trophic and phenotypic changes in response to stimulation with angiotensin II. Arterioscler Thromb Vasc Biol 1997; 17: 257-264.

    Google Scholar 

  60. Otsuka S, Sugano M, Makino N, et al. Interaction of mRNAs for angiotensin II type I and type 2 receptors to vascular remodeling in spontaneously hypertensive rats. Hypertension 1998; 32: 467-472.

    Google Scholar 

  61. Li D, Yang B, Philips MI, et al. Proapoptotic effects of ANG II in human coronary artery endothelial cells: Role of AT1 receptor and PKC activation. Am J Physiol 1999; 276: H786-H792.

    Google Scholar 

  62. Communal C, Singh K, Pimentel DR, et al. Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway. Circulation 1998; 98: 1329-1334.

    Google Scholar 

  63. Shizukuda Y, Buttrick PM, Geenen DL, et al. Betaadrenergic stimulation causes cardiocyte apoptosis: In-fluence of tachycardia and hypertrophy. Am J Physiol 1998; 275: H961-H968.

    Google Scholar 

  64. Iwai-Kanai E, Hasegawa K, Araki M, et al. Alpha-and beta-adrenergic pathways differentially regulate cell typespecific apoptosis in rat cardiac myocytes. Circulation 1999; 100: 305-311.

    Google Scholar 

  65. Calderone A, Thaik CM, Takahashi N, et al. Nitric oxide, atrial natriuretic peptide, and cyclicGMPinhibit the growthpromoting effects of norepinephrine in cardiac myocytes and fibroblasts. J Clin Invest 1998; 101: 812-828.

    Google Scholar 

  66. Colombo F, Noel J, Mayers P, et al. Beta-adrenergic stimulation of rat cardiac fibroblasts promotes protein synthesis via the activation of phosphatidylinositol 3-kinase. J Mol Cell Cardiol 2001; 33: 1091-1106.

    Google Scholar 

  67. Li PF, Dietz R, von Harsdorf R. Superoxide induces apoptosis in cardiomyocytes, but proliferation and expression of transforming growth factor-beta1 in cardiac fibroblasts. FEBS Lett 1999; 448: 206-210.

    Google Scholar 

  68. Warren MC, Bump EA, Medeiros D, et al. Oxidative stressinduced apoptosis of endothelial cells. Free Radic Biol Med 2000; 29: 537-547.

    Google Scholar 

  69. Li PF, Dietz R, von Harsdorf R. Differential effect of hydrogen peroxide and superoxide anion on apoptosis and proliferation of vascular smooth muscle cells. Circulation 1997; 96: 3602-3609.

    Google Scholar 

  70. Rao GN, Berk BC. Active oxygen species stimulate vascular smooth muscle cell growth and proto-oncogene expression. Circ Res 1992; 70: 593-599.

    Google Scholar 

  71. Zhang HY, Gharaee-Kermani M, Phan SH. Regulation of lung fibroblast alpha-smooth muscle actin expression, contractile phenotype, and apoptosis by IL-1beta. J Immunol 1997; 158: 1392-1399.

    Google Scholar 

  72. Li W, Ye Y, Fu B, et al. Genetic deletion of AT2 receptor antagonizes angiotensin II-induced apoptosis in fibroblasts of the mouse embryo. Biochem Biophys Res Commun 1998; 250: 72-76.

    Google Scholar 

  73. Nakajima M, Hutchinson HG, Fujinaga M, et al. The angiotensin II type 2 (AT2) receptor antagonizes the growth effects of the AT1 receptor: Gain-of-function study using gene transfer. Proc Natl Acad Sci USA 1995; 92: 10663-10667.

    Google Scholar 

  74. Yamada T, Akishita M, Pollman MJ, et al. Angiotensin II type 2 receptor mediates vascular smooth muscle cell apoptosis and antagonizes angiotensin II type 1 receptor action: An in vitro gene transfer study. Life Sci 1998; 63: P L289-PL295.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Canada

    Denis deBlois, Sergei N. Orlov & Pavel Hamet

Authors
  1. Denis deBlois
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sergei N. Orlov
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Pavel Hamet
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

deBlois, D., Orlov, S.N. & Hamet, P. Apoptosis in Cardiovascular Remodeling—Effect of Medication. Cardiovasc Drugs Ther 15, 539–545 (2001). https://doi.org/10.1023/A:1013723922582

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1013723922582

Search

Navigation